Assessment of Enteral Baclofen Prescribing Practices for Infants With Hypertonia

Hope E DiTaranto1, Astrela Moore1, Rebecca Kendsersky1

  • 1Department of Pharmacy (HED, AM, RK, JZ), Children's Hospital of Philadelphia, Philadelphia, PA.

Insights

This study analyzed enteral baclofen use in infants under 12 months for hypertonia. Prescribing varied, but baclofen was generally safe and well-tolerated, offering insights for infant dosing.

Area of Science:

  • Pediatric Neurology
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Hypertonia in infants often requires management with medications like baclofen.
  • Existing dosing guidance for infant baclofen is limited, leading to practice variability.

Purpose of the Study:

  • To describe the enteral baclofen prescribing patterns in infants 12 months of age and younger.
  • To assess the safety and tolerability of baclofen regimens in this population.

Main Methods:

  • A single-center, retrospective review of infants receiving enteral baclofen from January 2013 to December 2022.
  • Analysis of regimen details: dose, frequency, age, weight, and treatment duration.
  • Evaluation of outcomes including place in therapy, safety, and tolerability.

Main Results:

  • 108 infants with 423 baclofen regimens were analyzed.
  • Initiation doses were generally lower than recommended, with a median weight-based total daily dose (wTDD) of 0.5 mg/kg/day.
  • The longest-tolerated regimen had a median wTDD of 1.3 mg/kg/day; adverse effects were infrequent (3.7%).

Conclusions:

  • Infant baclofen prescribing for hypertonia shows significant variability in practice.
  • The analyzed baclofen regimens were found to be safe and well-tolerated in infants.
  • Findings offer valuable insights into current baclofen dosing strategies for pediatric hypertonia.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...